How do UK dentists deal with adverse drug reaction reporting?

J Yip, D R Radford, D Brown

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)

Abstract

• Highlights general dental practitioners were aware of the importance of detecting and reporting adverse drug reactions (ADRs).
• Reports that GDPs rarely see ADRs in practice.
• Recognises a need for additional education on ADR identification and reporting.
• Advises GDPs expressed a preference that ADR education should be delivered as continuing professional development.

Objective: Pilot investigation to establish the knowledge, use and education needs of general dental practitioners (GDPs) of the UK yellow card (YC) reporting scheme.

Design: Postal survey.

Main outcome measures: GDP views and experiences.

Results: Of 130 respondents, 74.6% were aware of the scheme. There was greater awareness of the scheme among those with more years in practice (p = 0.003) and those who had trained in the UK (p = 0.002). Six GDPs reported using the YC scheme in the past four years (estimated overall use: 0.01 of a YC per GDP per year); 88.5% had never used the YC scheme. The main reason given was that they never saw ADRs (58.5%). GDPs who had received their undergraduate training in the UK were more likely to be aware of their responsibility to report ADRs as a dentist than those who had trained outside the UK (p = 0.009). While GDPs were able to identify a wide range of sources to help them learn about ADRs, over three quarters of respondents (76.9%) expressed a need for additional postgraduate training.

Conclusions: Under-reporting of ADRs by healthcare professionals is a recognised phenomenon and GDPs appear to be no exception. The effect of providing additional postgraduate training on ADR reporting should be investigated.
Original languageEnglish
Pages (from-to)E22
JournalBritish Dental Journal
Volume214
Issue number8
DOIs
Publication statusPublished - Apr 2013

Fingerprint

Dive into the research topics of 'How do UK dentists deal with adverse drug reaction reporting?'. Together they form a unique fingerprint.

Cite this